Page 107 - Extensive Coverage News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Extensive coverage. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Extensive Coverage Today - Breaking & Trending Today

The Adrenomyeloneuropathy Treatment Market to grow on an emphatic note from 2019 to 2029


Search jobs
The Adrenomyeloneuropathy Treatment Market to grow on an emphatic note from 2019 to 2029
Adrenomyeloneuropathy is a rare genetic neuro-degenerative disease. Adrenomyeloneuropathy is the adult onset of adrenoleukodystrophy caused by the mutation in ABCD1 gene occurs usually in young boys. Adrenomyeloneuropathy disease affect the nerve cells in the spine and brain and the adrenal glands. Adrenomyeloneuropathy symptoms includes stiffness, weakness and pain in the legs. Adrenomyeloneuropathy is also known as ‘progressive spastic paraparesis. Damage to the nerves of the legs which causes unsteadiness and fall, also the bladder, bowel and sexual organs are affected by the adrenomyeloneuropathy. Rare diseases affect vast numbers of people, with current data representing 30 million sufferers in the EU alone and 30 million affected in the US. There is no cure to Adrenomyeloneuropathy. However some treatment might stop the progression of Adren ....

New York , United States , Novadip Biosciences , Asia Pacific , States Europe , Cytori Therapeutics , Rare Diseases Information Center , Persistence Market Research , Life Sciences Transformational Health Landscape , Request Methodology , North America , United States Europe , Middle East , Adrenomyeloneuropathy Treatment , Ascend Biopharmaceuticals , Eureka Therapeutics , Human Longevity , Allogene Therapeutics , Biorestorative Therapies , Immatics Biotechnologies , Newlink Genetics , Talaris Therapeutics , Can Request , Extensive Coverage , Market Research , Floornew York City ,